Gram Negative Rods
Gram Negative Rods
General Classification
Based on source or site of infection
1. Enteric tract
2. Respiratory tract
3. Animal sources
Enteric tract
E.g., Escherichia, Salmonella ,Shigella, vibrio, Campylobacter ,Klebsiella-
Enterobacter-Serratia group, Proteus-Providencia-Morganella group, Pseudomonas,
Bacteroides
Respiratory tract:
E.g., Hemophilus, Legionella, Bordetella
Animal sources:
E.g., Brucella, Francisella, Pasteurella, Yersinia
Escherichia coli
v The most common cause of sepsis among negative rods.
v One of the 2 important causes of neonatal meningitis (the other is the group B
streptococci) due to colonization of vagina by these organisms in about 25% of pregnant
women.
Virulence factors:
v Pili
v Capsule
v Endotoxin
v Two exotoxins (enterotoxins).
Pathogenesis
Types of E. Coli :
Ø Enteropathogenic E. coli (EPEC)
Ø Enterotoxigenic E. coli (ETEC)
Ø Enter invasive E. coli (EIEC)
Ø Enterohemorrhagic E. coli (EHEC)
Ø Enteradherent E. coli (EAEC)
q Urinary Tract Infections (UTIs:
v The most common agent for UTI (Cystitis, pyelonephritis): fever, chills, flank
pain.
v Occurs primarily in women.
v Attributed to 3 features which facilitate ascending infection into bladder:
Ø A short urethra
Ø Proximity of the urethra to the anus
Ø Colonization of vagina by members of fecal flora.
v The most frequent cause of nosocomial UTI. (equally in both men and women
and associated with using catheters)
q Systemic infection :
v Capsule and endotoxin play a prominent role.
v Capsular polysaccharide interferes with phagocytosis (Serotype having K1 causes
neonatal meningitis).
v LPS during sepsis causes fever, hypotension and disseminated intravascular
coagulation.
q Treatment:
v Antibiogram for most infections.
v A combination of ampicillin and gentamicin in neonatal meningitis
v Rehydration for diarrhea.
q Prevention
v No passive or active immunization.
v Prompt withdrawal of catheters and intravenous lines
v Caution regarding uncooked food and unpurified water while traveling.
Shigella
q Important properties
q Disease:
5
Diseases
q Enterocolitis
v An invasion of the epithelial and subepithelial tissue of the small and large intestines.
v Penetration both through and between the mucosal cells: Inflammation and diarrhea.
v PMN response limits the infection to the gut and the adjacent mesenteric lymph nodes.
v The dose of Salmonella required: at least 100,000 while for Shigella: 100 organisms.
q Typhoid (Enteric fevers):
v Infection begins in the small intestine but few gastrointestinal symptoms occur.
v The organisms multiply in the mononuclear phagocytes of peyer’s patches,
then spread to the phagocytes of the liver, gallbladder and spleen leading to
bacteremia and then fever.
q Septicemia:
v Accounts for only about 5-10% of Salmonella infections and occurs in:
q Enterocolitis
v Typhoid or Enteric fever caused by S. typhi and S. paratyphi (A, B and C).
v The illness is slow, with fever and constipation rather than vomiting and diarrhea.
v Rose spot (rose-colored papules) on the abdomen are associated with typhoid
fever but occur only rarely.
v The disease begins to resolve by the third week but intestinal hemorrhage or
perforation can occur.
Symptoms:
v Fever
v Little or no enterocolitis
v Focal symptoms: bone, lung, or meninges.
59Transmission of salmonella
v Human sources are either persons who temporarily excrete the organism
during or shortly after enterocolitis or chronic carriers who excrete the
organism for years.
Cont.,
v The most frequent animal source is poultry and eggs, but meat products
that are inadequately cooked have been implicated as well.
q Enterocolitis:
v Self-limited.
v Fluid and electrolyte replacement.
v Antibiotic can select mutants resistant and increase the frequency of
the carrier state.
v Antimicrobial agents are indicated only for neonates or persons with
chronic disease who are at risk of septicemia and disseminated
abscesses.
Treatment
v Ampicillin or chloramphenicol.
v Ampicillin: in patients who are chronic carriers of S. typhi.
v Cholecystectomy may be necessary to abolish the chronic carrier state.
v Focal abscesses should be drained.
Prevention
Vibrio cholerae
Ø Facultative anaerobic
Ø Can tolerate pH=9
Ø Fermenting sucrose
Ø Oxidase positive
Ø Monotricus flagellum
Epidemiology
q Asymptomatic carriers:
Ø Individuals in the incubation or convalescing (Recovery) period
q Recent pandemic:
Ø 1960s-1970s, over 3 continents (Africa, Europe and Asia)
Ø El Tor biotype/ usually Ogawa serotype.
Factors predisposing to epidemics
v Poor sanitation
v Malnutrition
v Overcrowding and
v Inadequate medical services.
v Quarantine measures failed to prevent the spread of the disease due
to many asymptomatic carriers.
9
Pathogenesis
v Approximately, 10% of people carry it in the normal flora of the colon and
on the skin in moist areas.
v Can cause infections virtually anywhere in the body, but more frequent
in:
Ø Urinary tract infections (UTIs)
Ø Pneumonia
Ø External otitis
Ø Wound infections (especially burns).
v From these sites, the organism can enter the blood, causing sepsis with
mortality rate of over 50%.
Treatment & Prevention
1 Prevention
Microscopy:
v Demonstrating spirochetes by darkfield or immunofluorescence
microscopy.
v Nonspecific serologic tests
v Nontreponemal antigens (extracts of normal mammalian tissues. eg.
Cardiolipin from beef heart) react with “reagin” antibodies in serum
samples from patients with syphilis.
v VDRL (Venereal Disease Research Laboratory)
v RPR (Rapid plasma reagin)
Cont.,
v Antibodies are detectable in the majority of patients at the time the primary lesion
appears.
Prevention:
Ø Administration of antibiotic after suspected exposure.
Ø The presence of any sexually transmitted disease makes testing for syphilis
mandatory.
Ø No vaccine is available.